Antidepressants in Oral Health
Antidepressants in Oral Health
DOI:
https://doi.org/10.70284/njirm.v4i3.540Keywords:
Antidepressants, chronic orofacial pain, therapeutic uses, adverse effectsAbstract
Orofacial pain has been one of the most perplexing conditions afflicting mankind. In an attempt to overcome pain, various drugs have been tried with success and limitations. Antidepressants have appreciable analgesic effect for the treatment of chronic orofacial pain. A sound knowledge of its effectiveness and safety is mandatory for the oral physicians. This article reviews the therapeutic and adverse effects of antidepressants.
References
1. Antidepressant drug update2006
2. Gray AM, Pache DM, Sewell RD (1999) Do alpha 2 adrenoreceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol 378 (2):161-168.
3. Ogata N, Yoshii M ,Narahashi T (1989)psychotropic drugs block voltage gated ion channels in neuroblastoma cells .Brain Res 476(1):140-144.
4. Gerner P,Haderer AE,Mujtaba M,et al (2003) assessment of differential blockade by amitriptyline and its N-methyl derivative in different species by different routes. Anesthesiology 98 (6):1484-1490.
5. Nakashita M,Sasaki K,Sakai N,et al (1997),effects of tricyclic and tetracyclic antidepressants on the three subtypes of GABA transporter.Neurosci Res 29(1) :87-91.
6. Abdel salam OM,Baiuomy AR ,Arbid MS (2004) Studies on the anti-inflammatory effect of Fluoxetine in the rat .Pharmacol Res 49 (2) :119-131.
7. Merskey H,Bogduk N,editors.classification of chronic pain,task force on taxonomy,international association for the study of pain.2nd edition seattle:IASP press;1994.
8. Feinmann C ,psychogenic facial pain: presentation and treatment.j psychsom res 1983;27:403-10
9. Sharav Y ,Singer E,Schmidt E,,et al,the analgesic effect of amitryipltyline on chronic facial pain. Pain 1987;31:199-209
10. Robert G Godfrey,a guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes, Arch intern med ,1996;156:1047-1052
11. Graff –Radford SB ,Solberg WK Atypical odontalgia. J Craino mandib Disord Facial Oral Pain 1992;6:260-266
12. Forssell H,Tasmuth T,Tenovuo O, et al (2004) Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial . j orofac pain 18 (2) :131-137.
13. Rizzatti barbosa CM, Nogueira MTP,de Andrade ED et al ,clinical evaluation of amitriptyline for control of chronic pain caused bytemporomandibular joint disorders J Craniomandib Pract 2003;21:221-5
14. O.Plesh, D.Curtis, J. Levine, W.D.Mccall JR, Journal of Oral Rehabilitation 2000, 27; 834-841.
15. Med Oral Patol Oral Cir Bucal. 2008( to be confirmed)
16. Adelman LC,Adelman JU,Von Seggern R ,et al (2000) Venlafaxine extended release (XR) for The Prophylaxis of migraine and tension type headache : a retrospective study in a clinical setting . Headache 40 (7):572-580
17. Brown GR. Herpes Zoster: Correlation of age, sex, distribution, neuralgia and associated disorders. South med j 1976;69:576-578
18. Watson CP, Vernich L, Chipman M ,Reed K. Nortryptiline versus amytryptiline in post herpetic neuralgia ; randomized trial. Neurology 1998:51:166-171
19. Rowbotham M, Harden N, Stacey B,etal. Gabapentine for the treatment of post herpetic neuralgia:a randomized control trial. JAMA 1998;280:1837-42.
20. Jeffrey P Okeson Bell’s Orofacial pain sixth ed pg 493
21. Gorsky M, Silverman S Jr, Chin h. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of130 patients. Oral Surg Oral Med Oral Pathol 1991, 72:192-195.
22. Rozen TD, Relief of anesthesia dolorosa with gabapentine. Headache1999:39;761-762
23. Orofacial pain and headache ,Yair Sharav,Rafael Benoliel, Pharmacotherapy of chronic orofacial pain; pg 382
24. Semenchuk MR, Sherman S, Davis B (2001) double blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 57 (90):1583-1588
25. Martin S. Greenberg, Michael Glick, jonathan A.Ship “Burket’s Oral medicine eleventh edi pg-188.
26. Hurt R, Sachs D, Glover E, Offord K, Johnston J, Dale L, Sullivan P, et al. A comparison of sustained-release bupropion and placebo for smoking cessation, New England Journal of Medicine. 337:1195-202. October 23, 1997.
2. Gray AM, Pache DM, Sewell RD (1999) Do alpha 2 adrenoreceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds? Eur J Pharmacol 378 (2):161-168.
3. Ogata N, Yoshii M ,Narahashi T (1989)psychotropic drugs block voltage gated ion channels in neuroblastoma cells .Brain Res 476(1):140-144.
4. Gerner P,Haderer AE,Mujtaba M,et al (2003) assessment of differential blockade by amitriptyline and its N-methyl derivative in different species by different routes. Anesthesiology 98 (6):1484-1490.
5. Nakashita M,Sasaki K,Sakai N,et al (1997),effects of tricyclic and tetracyclic antidepressants on the three subtypes of GABA transporter.Neurosci Res 29(1) :87-91.
6. Abdel salam OM,Baiuomy AR ,Arbid MS (2004) Studies on the anti-inflammatory effect of Fluoxetine in the rat .Pharmacol Res 49 (2) :119-131.
7. Merskey H,Bogduk N,editors.classification of chronic pain,task force on taxonomy,international association for the study of pain.2nd edition seattle:IASP press;1994.
8. Feinmann C ,psychogenic facial pain: presentation and treatment.j psychsom res 1983;27:403-10
9. Sharav Y ,Singer E,Schmidt E,,et al,the analgesic effect of amitryipltyline on chronic facial pain. Pain 1987;31:199-209
10. Robert G Godfrey,a guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes, Arch intern med ,1996;156:1047-1052
11. Graff –Radford SB ,Solberg WK Atypical odontalgia. J Craino mandib Disord Facial Oral Pain 1992;6:260-266
12. Forssell H,Tasmuth T,Tenovuo O, et al (2004) Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial . j orofac pain 18 (2) :131-137.
13. Rizzatti barbosa CM, Nogueira MTP,de Andrade ED et al ,clinical evaluation of amitriptyline for control of chronic pain caused bytemporomandibular joint disorders J Craniomandib Pract 2003;21:221-5
14. O.Plesh, D.Curtis, J. Levine, W.D.Mccall JR, Journal of Oral Rehabilitation 2000, 27; 834-841.
15. Med Oral Patol Oral Cir Bucal. 2008( to be confirmed)
16. Adelman LC,Adelman JU,Von Seggern R ,et al (2000) Venlafaxine extended release (XR) for The Prophylaxis of migraine and tension type headache : a retrospective study in a clinical setting . Headache 40 (7):572-580
17. Brown GR. Herpes Zoster: Correlation of age, sex, distribution, neuralgia and associated disorders. South med j 1976;69:576-578
18. Watson CP, Vernich L, Chipman M ,Reed K. Nortryptiline versus amytryptiline in post herpetic neuralgia ; randomized trial. Neurology 1998:51:166-171
19. Rowbotham M, Harden N, Stacey B,etal. Gabapentine for the treatment of post herpetic neuralgia:a randomized control trial. JAMA 1998;280:1837-42.
20. Jeffrey P Okeson Bell’s Orofacial pain sixth ed pg 493
21. Gorsky M, Silverman S Jr, Chin h. Clinical characteristics and management outcome in the burning mouth syndrome. An open study of130 patients. Oral Surg Oral Med Oral Pathol 1991, 72:192-195.
22. Rozen TD, Relief of anesthesia dolorosa with gabapentine. Headache1999:39;761-762
23. Orofacial pain and headache ,Yair Sharav,Rafael Benoliel, Pharmacotherapy of chronic orofacial pain; pg 382
24. Semenchuk MR, Sherman S, Davis B (2001) double blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology 57 (90):1583-1588
25. Martin S. Greenberg, Michael Glick, jonathan A.Ship “Burket’s Oral medicine eleventh edi pg-188.
26. Hurt R, Sachs D, Glover E, Offord K, Johnston J, Dale L, Sullivan P, et al. A comparison of sustained-release bupropion and placebo for smoking cessation, New England Journal of Medicine. 337:1195-202. October 23, 1997.
Downloads
Published
2013-06-30
How to Cite
Sodhi, A., V, A., & Mehta, R. (2013). Antidepressants in Oral Health: Antidepressants in Oral Health. National Journal of Integrated Research in Medicine, 4(3), 147–151. https://doi.org/10.70284/njirm.v4i3.540
Issue
Section
Review Article
